Navi
Right
 
Skip Navigation LinksHome Research report list Pharma & Healthcare Healthcare Global Parkinson's Disease Market DataPack - 2016 Edition
 
Social
Global Parkinson's Disease Market DataPack - 2016 Edition
Format : Pdf (Instant Download)
Date: 06, September 2016 | Pages: 58
Social
 
Electronic Access - Single User License
Tool
USD 450
Electronic Access - Corporate User License
Tool
USD 550
Hard Copy - Mail Delivery
Tool
USD 500
 
   
 

The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research.


The market figures and industry dynamics are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.


It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers.


It also explores the competitive landscape of the respective market with focus on major players.


The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.


Our success parameter is very simple - impact of our services on our clients' business. We provide high quality, cost effective research and analysis to support decision making processes for industry professionals. Our strength lies in the reliability of our research and on the value added analysis that we provide.


We have a team of research analysts who have mastered the skill of preparing flawless market intelligence reports to help clients maximize their productivity and return on investment. Our analysts have great expertise to assess current trends in business practices, product promotion and market competition.

 

Currently Leading Treatment Drugs for Parkinson’s Disease
Selected Late-Stage Drugs for Parkinson’s
Global Parkinson’s Disease Drug Market by Value (2010-2015E)
Global Parkinson’s Disease Drug Market by Region (2014)
Global Parkinson’s Disease Market by Drug Class (2015E)
Global Parkinson’s Disease Patient Population by Severity (2015E)
Global Parkinson’s Disease Patient Population by Region (2015E)
The U.S. Parkinson’s Disease Market by Value & Volume (2013-2020E)
The U.S. Parkinson’s Disease Market Value by Category (2013-2017E)
The U.S. Parkinson’s Disease Market Volume by Category (2015)
The U.S. Parkinson’s Disease Market by Drug Class (2015)
The U.S. Parkinson’s Branded Drugs Market by Value & Volume (2013-2020E)
The U.S. Parkinson’s Generic Drugs Market by Value & Volume (2013-2020E)
The E.U. Parkinson’s Disease Prevalence and Diagnosis (2013-2018E)
The European* Parkinson’s Disease Drug Market by Value (2014/2015)
Japan’s Parkinson’s Disease Drug Market by Value (2014/2015)
Global Lead Production (2000-2014)
Global Life Expectancy at Birth (2008-2014E)
Global Male Population (2009-2014)
Global Ageing Population above 65 Years (2009-2014)
Global Healthcare Expenditure (2009-2014)
Selected Late-Stage Drugs for Parkinson’s Disease
Biologics under Development for Parkinson’s Disease
The U.S Parkinson’s Disease Branded Market by Drug (2015)
The U.S. Parkinson’s Disease Generic Market by Drug (2015)
Portfolio of Innovative CNS Medicines
Biotie Therapies Corp Revenue & Net Income/Loss (2011-2015)
Biotie’s Research and Development Expenditure (2011-2015)
Adamas Pharmaceuticals Therapeutic Portfolio
Adamas Pharmaceuticals Revenue and Net Income/Loss (2012-2015)
Adamas Pharmaceutical’s R&D Expenditure (2012-2015)
Lundbeck’s Revenue Share by Product (2014)
Lundbeck’s Revenue Share by Region (2014)
Lundbeck’s Revenue and Annual Growth (2012-2017E)
Lundbeck’s Product Pipeline
Novartis Revenue by Business Segments (2015)
Novartis Revenue and Net Income (2011-2015)
Global Parkinson’s Disease Market Forecast (2013-2017F)
Dependent and Independent Variable
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output 

Currently Leading Treatment Drugs for Parkinson’s Disease
Selected Late-Stage Drugs for Parkinson’s
Global Parkinson’s Disease Drug Market by Value (2010-2015E)
Global Parkinson’s Disease Drug Market by Region (2014)
Global Parkinson’s Disease Market by Drug Class (2015E)
Global Parkinson’s Disease Patient Population by Severity (2015E)
Global Parkinson’s Disease Patient Population by Region (2015E)
The U.S. Parkinson’s Disease Market by Value & Volume (2013-2020E)
The U.S. Parkinson’s Disease Market Value by Category (2013-2017E)
The U.S. Parkinson’s Disease Market Volume by Category (2015)
The U.S. Parkinson’s Disease Market by Drug Class (2015)
The U.S. Parkinson’s Branded Drugs Market by Value & Volume (2013-2020E)
The U.S. Parkinson’s Generic Drugs Market by Value & Volume (2013-2020E)
The E.U. Parkinson’s Disease Prevalence and Diagnosis (2013-2018E)
The European* Parkinson’s Disease Drug Market by Value (2014/2015)
Japan’s Parkinson’s Disease Drug Market by Value (2014/2015)
Global Lead Production (2000-2014)
Global Life Expectancy at Birth (2008-2014E)
Global Male Population (2009-2014)
Global Ageing Population above 65 Years (2009-2014)
Global Healthcare Expenditure (2009-2014)
Selected Late-Stage Drugs for Parkinson’s Disease
Biologics under Development for Parkinson’s Disease
The U.S Parkinson’s Disease Branded Market by Drug (2015)
The U.S. Parkinson’s Disease Generic Market by Drug (2015)
Portfolio of Innovative CNS Medicines
Biotie Therapies Corp Revenue & Net Income/Loss (2011-2015)
Biotie’s Research and Development Expenditure (2011-2015)
Adamas Pharmaceuticals Therapeutic Portfolio
Adamas Pharmaceuticals Revenue and Net Income/Loss (2012-2015)
Adamas Pharmaceutical’s R&D Expenditure (2012-2015)
Lundbeck’s Revenue Share by Product (2014)
Lundbeck’s Revenue Share by Region (2014)
Lundbeck’s Revenue and Annual Growth (2012-2017E)
Lundbeck’s Product Pipeline
Novartis Revenue by Business Segments (2015)
Novartis Revenue and Net Income (2011-2015)
Global Parkinson’s Disease Market Forecast (2013-2017F)
Dependent and Independent Variable
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output 

One can also purchase any particular sections from this report. Please send us an email to info@konceptanalytics.com with your order details.
 
 
About Us    |    PRESS RELEASES    |    RESEARCH REPORTS    |    Contact Us    |    PRIVACY POLICY    |    REFUND POLICY
@ Copyright 2014 Koncept Analytics Pvt Ltd. All Rights Reserved. Web Developed By Vision IT Consultants Pvt Ltd.